 |
 |

Interferon Therapy for Laryngeal Papillomatosis in Adults
Axel Bomholt, MD
Arch Otolaryngol. 1983;109(8):550-552.
Abstract
Eight patients with recurrent laryngeal papillomatosis were treated with exogenous leukocyte interferon , 1 to 4 x 106 IU daily or every second day for 150 days. During an initial three-week period of low-dose treatment, tumor size was reduced in five patients. After three weeks of treatment, microsurgical removal was performed, followed by increased dosage of interferon. At the end of the five-month treatment, recurrence of small papillomas was found in one of the patients. During the posttreatment period (seven to 11 months), recurrences occurred in four patients. We conclude from this pilot study that exogenous leukocyte interferon changes the pattern of recurrences of laryngeal papillomas in adults and may supplement surgical treatment.
(Arch Otolaryngol 1983;109:550-552)
Author Affiliations
From the Ear, Nose, and Throat Department, Roskilde (Denmark) Hospital.
Footnotes
Accepted for publication Nov 30, 1982.
Reprint requests to Ear, Nose, and Throat Department, Roskilde Hospital, DK-4000 Roskilde, Denmark (Dr Bomholt).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Randomized Surgical Adjuvant Trial of Interferon Alfa-n1 in Recurrent Papillomatosis
Leventhal et al.
Arch Otolaryngol Head Neck Surg 1988;114:1163-1169.
ABSTRACT
Persistence and Expression of Human Papillomavirus During Interferon Therapy
Steinberg et al.
Arch Otolaryngol Head Neck Surg 1988;114:27-32.
ABSTRACT
Hematoporphyrin Derivative Therapy of Papillomas: Experimental Study
Shikowitz et al.
Arch Otolaryngol Head Neck Surg 1986;112:42-46.
ABSTRACT
|